Drug intelligence / Profile preview

prim-o-glucosylcimifugin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Prim-o-glucosylcimifugin is a bioactive chromone glycoside and a major constituent of the traditional Chinese medicinal herb *Saposhnikovia divaricata* (Radix Saposhnikoviae), as well as being found in other plants such as *Angelica japonica*. It is classified chemically as an organic heterotricyclic compound and oxacycle. Prim-o-glucosylcimifugin exhibits notable anti-inflammatory and antioxidant properties. Mechanistically, it inhibits the proliferation of smooth muscle cells stimulated by TNF-alpha and exerts anti-inflammatory effects by inhibiting inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX‑2) expression through suppression of JAK2/STAT3 signaling pathways. It also reduces nitric oxide production in activated macrophages. The compound is widely used in research for its potential therapeutic applications in inflammation-related conditions, antioxidant support, natural product validation, food preservation due to its antioxidative capacity, cosmetic formulations for skin health benefits, and various biotechnological applications[1][2][3][4][6][7].

Other names
prime-O-glucosylcimifugin5H-Furo[3,2-g][1]benzopyran-5-one,7-[(beta-D-glucopyranosyloxy)methyl]-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-, (S)-80681-45-4
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)JAK2 (Janus kinase 2)STAT3 (Signal Transducer and Activator of Transcription 3)TNFA (Tumor necrosis factor alpha (soluble))NOS2 (Nitric Oxide Synthase 2)

Beyond the preview

Go deeper on prim-o-glucosylcimifugin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on prim-o-glucosylcimifugin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call